tiprankstipranks
Advertisement
Advertisement
Signatera CDx approved by FDA as companion diagnostic in MIBC
PremiumThe FlySignatera CDx approved by FDA as companion diagnostic in MIBC
15d ago
Cathie Wood’s ARK Investment buys 17.3K shares of Natera today
Premium
The Fly
Cathie Wood’s ARK Investment buys 17.3K shares of Natera today
17d ago
Natera price target raised to $249 from $240 at Piper Sandler
Premium
The Fly
Natera price target raised to $249 from $240 at Piper Sandler
18d ago
Natera price target raised to $265 from $260 at JPMorgan
PremiumThe FlyNatera price target raised to $265 from $260 at JPMorgan
22d ago
Natera price target raised to $220 from $215 at Wells Fargo
Premium
The Fly
Natera price target raised to $220 from $215 at Wells Fargo
22d ago
Natera: Strong Q1 Beat, Raised Guidance Support Buy Rating with Unchanged $280 Price Target
Premium
Ratings
Natera: Strong Q1 Beat, Raised Guidance Support Buy Rating with Unchanged $280 Price Target
22d ago
Natera initiated with an Outperform at William Blair
PremiumThe FlyNatera initiated with an Outperform at William Blair
2M ago
Natera: Premium-Valued Leader in MRD Positioned for Long-Term Growth and Margin Expansion
Premium
Ratings
Natera: Premium-Valued Leader in MRD Positioned for Long-Term Growth and Margin Expansion
2M ago
Natera highlights Allogene Therapeutics’ analysis from ALPHA3 trial
Premium
The Fly
Natera highlights Allogene Therapeutics’ analysis from ALPHA3 trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100